Study details
Enrolling now
Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer
Albany Medical College
NCT IDNCT06517901ClinicalTrials.gov data as of Apr 2026
Target enrollment
1,306
Study length
about 2.2 years
Ages
18+
Sex
Male only
Locations
3 sites in MA, NY, PA
What this study is about
Researchers are testing whether cognitive fusion or software fusion ultrasound-guided biopsies are better at detecting prostate cancer in men with suspicious lesions on MRI. The trial will compare the detection rates of clinically significant prostate cancer following either the cognitive or the fusion targeted prostate biopsy.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Undergo Cognitive fusion prostate biopsy
- 2.Undergo Software fusion prostate biopsy
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Procedures
biopsy
Body systems
Oncology